ArticleParasites & vectors2025
Eimeria tenella apical membrane 2 overexpression enhances pathogenicity and immunity in chickens.
Article in Parasites & vectors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundEimeria tenella, a highly pathogenic apicomplexan parasite, causes severe avian coccidiosis, threatening global poultry production. Apical membrane antigens (AMAs), conserved proteins in apicomplexan parasites, are critical for host cell invasion, making them promising vaccine targets. In this study, we constructed an the overexpression strain of E. tenella AMA2 (EtAMA2-OE) and evaluated its pathogenicity and immunogenicity.
methodsTranscriptional profiling of EtAMA2 during infection was conducted using reverse transcription quantitative real-time polymerase chain reaction (RT-qPCR). A homozygous EtAMA2-OE strain was generated using plasmid transfection, drug selection, and flow cytometry. Pathogenicity was assessed through in vitro sporozoite invasion assays and in vivo evaluations, including cecal lesion scoring, oocyst shedding, and weigh-gain monitoring in chicks. Furthermore, immunogenicity was evaluated by challenging immunized chicks with wild-type E. tenella.
resultsThe EtAMA2-OE strain significantly enhanced invasion efficiency and pathogenicity, causing severe cecal pathology, increased oocyst output, and weight loss. Importantly, immunization with EtAMA2-OE conferred substantial immunity, resulting in significantly reduced oocyst shedding and markedly attenuated cecal lesions in immunized chicks.
conclusionsThe present data indicated that EtAMA2 had dual functions as a virulence factor critical for early invasion and a promising vaccine antigen. This study thereby provided new insights for future drug target screening and development of a vaccine against coccidiosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.